These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Some cardiovascular effects of cyclocytidine. Herman EH; Chadwick DP Cancer Treat Rep; 1976 Nov; 60(11):1663-6. PubMed ID: 66094 [No Abstract] [Full Text] [Related]
27. Positive inotropic but no relaxant effects of phenylephrine in cat papillary muscle. Meinertz T; Schmelzle B; Scholz H J Cyclic Nucleotide Res; 1978 Aug; 4(4):291-8. PubMed ID: 214466 [TBL] [Abstract][Full Text] [Related]
28. Cardiovascular properties of a new cardiotonic agent, MDL 19205. Dage RC; Roebel LE; Hsieh CP; Woodward JK J Cardiovasc Pharmacol; 1984; 6(1):35-42. PubMed ID: 6199609 [TBL] [Abstract][Full Text] [Related]
29. The action of propranolol on the dog heart. Harry JD; Linden RJ; Snow HM Br J Pharmacol; 1972 May; 45(1):155P-156P. PubMed ID: 4402822 [No Abstract] [Full Text] [Related]
30. Possible role of cyclic AMP in the relaxation process of mammalian heart: effects of dibutyryl cyclic AMP and theophylline on potassium contractures in cat papillary muscles. Meinertz T; Nawrath H; Scholz H Naunyn Schmiedebergs Arch Pharmacol; 1976 May; 293(2):129-37. PubMed ID: 183151 [TBL] [Abstract][Full Text] [Related]
31. Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol. Glick G; Parmley WW; Wechsler AS; Sonnenblick EH Circ Res; 1968 Jun; 22(6):789-99. PubMed ID: 5659816 [No Abstract] [Full Text] [Related]
32. Effects of 8-S-benzyl cyclic AMP on mechanical characteristics and cyclic AMP levels of the canine ventricular myocardium. Endoh M; Nakamura M Eur J Pharmacol; 1980 Mar; 62(1):63-72. PubMed ID: 6154588 [No Abstract] [Full Text] [Related]
33. [Restoration of the automatic contractile activity of K+-arrested heart muscle cells in culture by means of dibutyryl-3', 5'-adenosine monophosphate]. Warbanow W; Will-Shahab L; Wollenberger A Acta Biol Med Ger; 1975; 34(9):1553-6. PubMed ID: 176854 [TBL] [Abstract][Full Text] [Related]
35. Cardiovascular studies of 5-(3-tert-butylamino-2-hydroxy) propoxy-3,4-dihydrocarbostyril hydrochloride (OPC-1085), a new potent beta-adrenergic blocking agent. Yabuochi Y; Kinoshita D Jpn J Pharmacol; 1974 Dec; 24(6):853-61. PubMed ID: 4618580 [TBL] [Abstract][Full Text] [Related]
36. Effects of dibutyryl cyclic-AMP on cardiac output and myocardial contractility in dogs. Okuaki A Tohoku J Exp Med; 1977 Oct; 123(2):139-45. PubMed ID: 201047 [TBL] [Abstract][Full Text] [Related]
37. Positive inotropic and chronotropic effects of 8-substituted derivatives of 3',5'-cyclic AMP. Matsubara I; Imai S Jpn J Pharmacol; 1975 Oct; 25(5):599-601. PubMed ID: 176494 [No Abstract] [Full Text] [Related]
38. Effects of catecholamines, cyclic nucleotides and phosphodiesterase inhibitors on contractions of skeletal muscles in anaesthetized cats. Bowman WC; Nott MW Clin Exp Pharmacol Physiol; 1974; 1(4):309-23. PubMed ID: 4376475 [No Abstract] [Full Text] [Related]
39. Pharmacological evidence for catecholamine-independent contractile effects of X-537A on the isolated working rat heart preparation. Rodgers RL; Moore JI; Hornbrook KR Can J Physiol Pharmacol; 1979 Apr; 57(4):428-31. PubMed ID: 455144 [TBL] [Abstract][Full Text] [Related]
40. Adrenergic effects on force-frequency relationship: a pivotal role for the cardiac intrinsic systems. Mattera GG; Vanoli E; Martinez V; Luciani M; Falco T; Borsini F Acta Physiol (Oxf); 2011 Jun; 202(2):141-9. PubMed ID: 21338472 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]